Total 25-hydroxyvitamin D Levels Predict Fracture Risk: Results from the 15-year Follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2017 Mar 1

PMID 28243705

Citations 23

Authors

J Tamaki

M Iki

Y Sato

E Kajita

H Nishino

T Akiba

T Matsumoto

S Kagamimori

Affiliations

Soon will be listed here.

Abstract

Introduction: We examined whether total 25-hydroxyvitamin D (25[OH]D) levels are associated with fracture risk over 15 years in a Japanese female cohort.

Methods: Of 1437 community-dwelling women aged ≥50 years in the baseline survey, 1236 provided information regarding fractures during a 15-year follow-up period. The analysis included 1211 women without early menopause or diseases affecting bone metabolism.

Results: Over 15 years, 269 clinical (224 non-vertebral, 149 fragility) fracture events were confirmed. Incidence rates categorized by 25(OH)D levels (<10, 10-20, 20-30, and ≥30 ng/mL) indicated a significant divergence for any clinical fractures in 5 years (log rank test p = 0.016) and for non-vertebral fractures in 5, 10, and 15 years (p < 0.001, p = 0.001, p = 0.017, respectively). Hazard ratios (HRs) for 25(OH)D levels <10 and 10-20 ng/mL compared to levels ≥30 ng/mL during 5 years indicated significances for clinical fractures (HR 4.93 with p = 0.009, HR 3.00 with p = 0.034) and for non-vertebral fractures (HR 6.55 with p = 0.005, HR 3.49 with p = 0.036). Those with levels <20 ng/mL compared to those with levels ≥20 ng/mL indicated significant increased risks for clinical fractures (HR 1.72 with p = 0.010), non-vertebral fractures (HR 2.45 with p < 0.001), and fragility fractures (HR 2.00 with p = 0.032) in 5 years. The HR of non-vertebral fractures for levels <20 ng/mL remained significant during 15 years (HR 1.42 with p = 0.012) after adjustment for age and femoral neck bone mineral density.

Conclusions: Low 25(OH)D levels, especially <20 ng/mL, were associated with elevated fracture risks in Japanese women.

Citing Articles

Effect of Vitamin D and Skeletal Muscle Mass on Prognosis of Patients with Diffuse Large B-Cell Lymphoma.

Nakamura N, Kanemura N, Matsumoto T, Nakamura H, Shibata Y, Yamaguchi K Nutrients. 2024; 16(16).

PMID: 39203790 PMC: 11357194. DOI: 10.3390/nu16162653.

Therapeutic Intervention for Osteoporosis of Surgical Cases With Non-Vertebral Fractures for Three Years in a Newly Established Rural Hospital in Japan.

Nakayama M, Kiyota Y, Watanabe N, Yamanouchi K, Nakamura S, Takeshima K Cureus. 2024; 16(7):e63864.

PMID: 39100064 PMC: 11297664. DOI: 10.7759/cureus.63864.

Histomorphometric analysis of patients with femoral neck fracture and 25-hydroxyvitamin D deficiency: a cross-sectional study.

Okumura G, Yamamoto N, Suzuki H, Ninomiya H, Hirano Y, Tei Y J Bone Miner Metab. 2024; 42(2):214-222.

PMID: 38329506 DOI: 10.1007/s00774-024-01495-6.

The impact of chronic obstructive pulmonary disease on bone strength.

Tsukamoto M, Nabeshima T, Wang K, Mano Y, Arakawa D, Okada Y J Bone Miner Metab. 2024; 42(4):421-427.

PMID: 38326630 DOI: 10.1007/s00774-024-01496-5.

Seasonal Serum 25(OH) Vitamin D Level and Reproductive or Immune Markers in Reproductive-Aged Women with Infertility: A Cross-Sectional Observational Study in East Japan.

Ota K, Mitsui J, Katsumata S, Takayanagi Y, Nako Y, Tajima M Nutrients. 2023; 15(24).

PMID: 38140317 PMC: 10745323. DOI: 10.3390/nu15245059.

References

Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

Melhus H, Snellman G, Gedeborg R, Byberg L, Berglund L, Mallmin H . Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. J Clin Endocrinol Metab. 2010; 95(6):2637-45. DOI: 10.1210/jc.2009-2699. View

Palvanen M, Kannus P, Parkkari J, Pitkajarvi T, Pasanen M, Vuori I . The injury mechanisms of osteoporotic upper extremity fractures among older adults: a controlled study of 287 consecutive patients and their 108 controls. Osteoporos Int. 2001; 11(10):822-31. DOI: 10.1007/s001980070040. View

Bolland M, Grey A, Gamble G, Reid I . Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014; 2(7):573-80. DOI: 10.1016/S2213-8587(14)70068-3. View

Nussbaum S, Zahradnik R, Lavigne J, Brennan G, Kim L, Keutmann H . Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987; 33(8):1364-7. View

Chan R, Chan C, Woo J, Ohlsson C, Mellstrom D, Kwok T . Serum 25-hydroxyvitamin D, bone mineral density, and non-vertebral fracture risk in community-dwelling older men: results from Mr. Os, Hong Kong. Arch Osteoporos. 2012; 6:21-30. DOI: 10.1007/s11657-011-0053-0. View

Reid I, Bolland M . Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues?. Osteoporos Int. 2014; 25(10):2347-57. DOI: 10.1007/s00198-014-2749-7. View

Durazo-Arvizu R, Dawson-Hughes B, Sempos C, Yetley E, Looker A, Cao G . Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older. J Nutr. 2010; 140(3):595-9. PMC: 2821888. DOI: 10.3945/jn.109.116681. View

Weatherall M . A meta-analysis of 25 hydroxyvitamin D in older people with fracture of the proximal femur. N Z Med J. 2000; 113(1108):137-40. View

10.

Tanaka S, Kuroda T, Yamazaki Y, Shiraki Y, Yoshimura N, Shiraki M . Serum 25-hydroxyvitamin D below 25 ng/mL is a risk factor for long bone fracture comparable to bone mineral density in Japanese postmenopausal women. J Bone Miner Metab. 2013; 32(5):514-23. DOI: 10.1007/s00774-013-0520-3. View

11.

Yoshimura N, Muraki S, Oka H, Morita M, Yamada H, Tanaka S . Profiles of vitamin D insufficiency and deficiency in Japanese men and women: association with biological, environmental, and nutritional factors and coexisting disorders: the ROAD study. Osteoporos Int. 2013; 24(11):2775-87. DOI: 10.1007/s00198-013-2372-z. View

12.

Ross A, Manson J, Abrams S, Aloia J, Brannon P, Clinton S . The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2010; 96(1):53-8. PMC: 3046611. DOI: 10.1210/jc.2010-2704. View

13.

Bolland M, Grey A, Gamble G, Reid I . The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014; 2(4):307-320. DOI: 10.1016/S2213-8587(13)70212-2. View

14.

Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis J . Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014; 348:g2035. PMC: 3972415. DOI: 10.1136/bmj.g2035. View

15.

Shimizu Y, Kim H, Yoshida H, Shimada H, Suzuki T . Serum 25-hydroxyvitamin D level and risk of falls in Japanese community-dwelling elderly women: a 1-year follow-up study. Osteoporos Int. 2015; 26(8):2185-92. DOI: 10.1007/s00198-015-3130-1. View

16.

Pramyothin P, Techasurungkul S, Lin J, Wang H, Shah A, Ross P . Vitamin D status and falls, frailty, and fractures among postmenopausal Japanese women living in Hawaii. Osteoporos Int. 2009; 20(11):1955-62. DOI: 10.1007/s00198-009-0910-5. View

17.

Mizoue T, Kochi T, Akter S, Eguchi M, Kurotani K, Tsuruoka H . Low serum 25-hydroxyvitamin D concentrations are associated with increased likelihood of having depressive symptoms among Japanese workers. J Nutr. 2015; 145(3):541-6. DOI: 10.3945/jn.114.204115. View

18.

Looker A . Serum 25-hydroxyvitamin D and risk of major osteoporotic fractures in older U.S. adults. J Bone Miner Res. 2012; 28(5):997-1006. DOI: 10.1002/jbmr.1828. View

19.

Khaw K, Luben R, Wareham N . Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study. Am J Clin Nutr. 2014; 100(5):1361-70. PMC: 4196486. DOI: 10.3945/ajcn.114.086413. View

20.

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View